Fig. 2From: Rituximab, plasma exchange and immunoglobulins: an ineffective treatment for chronic active antibody-mediated rejectionEstimated glomerular filtrate rate (eGFR) follow-up before and after c-aABMR diagnose. a eGFR evolution of treated and control patient groups. b eGFR evolution according to graft outcome in both groups. Chronic active antibody-mediated rejection (c-aABMR)Back to article page